The purpose of this experiment is to encounter bacteria from tropical soils that have the capability of producing antibiotic. In order to do so, it was necessary to isolate the bacteria, purify it five times and freeze it at a temperature of -80˚C. After purification, gram staining was performed to classify the bacteria as gram positive or negative. The bacteria were characterized by doing purification of genomic DNA and then, a Polymerase Chain Reaction (PCR) with the primers 16sRNA, 16S_1510R and 16S_8F. An electrophoresis was conducted to see if the PCR process went well. The PCR product was purified and analyzed by using Bioinformatics. Finally, both bacteria’s S15UPRCRISENRE30M01 and S15UPRCRISEAFD30M01A had positive results as antibiotic producers for M.luteus.
bacterial secretion system, tpyes of different secretion system, type 3 secretion system , regulation, effectors role of effectors, host bactrial relation molecular activities of effectors, chaperons, atpase
Automated system for bacterial identificationDEEKSHANT KUMAR
[DOWNLOAD IT OPEN IT WITH MICROSOFT POWERPOINT THEN YOU WILL BE ABLE TO UNDERSTAND THE TOPIC COVERED.]
1. WHOLE TEXT IS RELIABLE.
2. TEXT HAS BEEN TAKEN FROM STANDARD TEXT BOOK FOR MEDICAL MICROBIOLOGY.
3. SOME PICTURE HAS BEEN TAKEN FROM JOURNAL.
bacterial secretion system, tpyes of different secretion system, type 3 secretion system , regulation, effectors role of effectors, host bactrial relation molecular activities of effectors, chaperons, atpase
Automated system for bacterial identificationDEEKSHANT KUMAR
[DOWNLOAD IT OPEN IT WITH MICROSOFT POWERPOINT THEN YOU WILL BE ABLE TO UNDERSTAND THE TOPIC COVERED.]
1. WHOLE TEXT IS RELIABLE.
2. TEXT HAS BEEN TAKEN FROM STANDARD TEXT BOOK FOR MEDICAL MICROBIOLOGY.
3. SOME PICTURE HAS BEEN TAKEN FROM JOURNAL.
A broad module on industrial microbiology is summarized with pictures .It includes the production of vitamins,vaccine ,alcohol,vinegar,steroids,amino acids ,antibiotics .it also includes the general idea on history ,media,equipment,fermentation,procedure ,uses of industrial microbiology .The production of wine,beer and vinegar are mine core interest .Hope may help ....Thank you .
SCP Nutraceutical Industry A small Overview
Single Cell Protein
Companies In the Domain
Indian Nutraceuticals
Food Supplements
Spirulina Benefits
Chlorella Benefits
Chlorella Companies
Spirulina Companies
Spirulina Tablets
Chlorella Tablets
Spirulina Capsules
Chlorella Capsules
Powder forms
Production Of SINGLE CELL PROTEINS
This ppt contains all types of Microbial Bioremediation methods . Everyone can understand clearly . Explaining with neat pictures and animation . Useful for presentation about Microbes in bioremediation . At last it contains a small animated video which helps to get clear view .
A broad module on industrial microbiology is summarized with pictures .It includes the production of vitamins,vaccine ,alcohol,vinegar,steroids,amino acids ,antibiotics .it also includes the general idea on history ,media,equipment,fermentation,procedure ,uses of industrial microbiology .The production of wine,beer and vinegar are mine core interest .Hope may help ....Thank you .
SCP Nutraceutical Industry A small Overview
Single Cell Protein
Companies In the Domain
Indian Nutraceuticals
Food Supplements
Spirulina Benefits
Chlorella Benefits
Chlorella Companies
Spirulina Companies
Spirulina Tablets
Chlorella Tablets
Spirulina Capsules
Chlorella Capsules
Powder forms
Production Of SINGLE CELL PROTEINS
This ppt contains all types of Microbial Bioremediation methods . Everyone can understand clearly . Explaining with neat pictures and animation . Useful for presentation about Microbes in bioremediation . At last it contains a small animated video which helps to get clear view .
Doctors Data Inc A Revolution in the Evaluation of Gastrointestinal MicrofloraBonnieReynolds4
Recent research regarding the gastrointestinal microbiome has irrefutably confirmed the fact that the
microbial inhabitants of the gastrointestinal tract, and their astonishing scope of metabolic activities,
are at the very core of health and numerous disease processes. It is also clear that clinical microbiology
testing should be optimized to address the relative abundance of all bacterial species present in a stool
specimen.
Assessment of the Coliform Bacterial Load of Some Drinking Water Sources in D...Scientific Review SR
Drinking water samples from 5 sachet water companies, 3 boreholes and 2 taps, collected from different locations of Dutse Metropolis of Jigawa State, Nigeria were analysed for coliform bacterial counts using the Membrane Filtration Technique. All the samples contained some amounts of total coliforms, but mostly within permissible levels. Thirty three percent (33%) of the samples from borehole, 60% from sachet water and 100% from the taps contained faecal coliforms, which indicates contamination. Cultures of the faecal coliforms obtained were morphologically identified using the gram-staining procedure and some series of biochemical tests were carried out in order to identify the organisms. The identified organisms were Escherichia coli (E. coli), Klebsiella sp. and Citrobacter sp. Presence of coliforms above the regulatory set standards indicates contamination and un-safeness of the water for drinking. Presence of organisms such as E. coli, Klebsiella sp. and Citrobacter sp. necessitates improvement in monitoring and water hygiene practices to improve the quality of drinking water in the study area.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
Explore our infographic on 'Essential Metrics for Palliative Care Management' which highlights key performance indicators crucial for enhancing the quality and efficiency of palliative care services.
This visual guide breaks down important metrics across four categories: Patient-Centered Metrics, Care Efficiency Metrics, Quality of Life Metrics, and Staff Metrics. Each section is designed to help healthcare professionals monitor and improve care delivery for patients facing serious illnesses. Understand how to implement these metrics in your palliative care practices for better outcomes and higher satisfaction levels.
Presentation: Isolation and Characterization of Bacteria from Tropical Soils
1. Isolation and Characterization of
Bacteria from Tropical Soils
Alejandra Ferrer1
Nicole S. Rivera1
Jessica Ortiz1
Carolina Huertas1
Dr. Michael Rubin
Date: May 15, 2015
RISE Program
Biology and Chemistry Department
University of Puerto Rico at Cayey
1 This author contributed equally to this project
2. Background
• Bacteria are prokaryotic microorganisms that can be differentiated by
their peptidoglycan layer located in the cell wall.
• This aspect classifies them as gram-positive or gram-negative.
3. Antibiotic Era
• The discovery of penicillin in 1928 was by Alexander Fleming.
• Since 1940’s scientists, using Fleming’s research as a source, have
been studying and developing antibiotics in order to reduce illness
and death from infectious diseases (CDC 2014).
• Rene Dubos- discovered and isolated an antibacterial compound
called tyrothricin.
• Recently, scientists have discovered a new antibiotic, from the soil,
which name is Teixobactin (Ling et al. 2015).
5. • Antibiotic resistance is produced when the capability of killing or
inhibiting bacterial growth is eliminated. The bacteria can grow in
the presence of the antibiotic (APUA 2014).
• In a recent investigation Walsh and colleagues (2003) isolated 412
antibiotic resistant bacteria from agricultural, urban, and pristine
soils.
6. Significance
● The importance of this study is that it attempts to find new
bacteria from tropical soils with antibacterial properties.
● This investigation responds to the need for new antibiotics that
can inhibit bacterial reproduction.
7. Problem
• Can we find bacteria in soil that have
useful properties such as antibiotic
production and antibiotic resistance?
8. Hypothesis
• It is hypothesized that different properties of the
isolated soil bacteria will be characterized such as
bacterial structure, antibiotic resistance and
antibiotic production .
• There will be more bacteria found in tropical soils
capable of antibiotic production and resistance .
(Dubisnky et al. 2010)
9. Goals
• Isolation, purification and freezing of soil bacteria
• Gram staining and colony morphology
• Test for antibiotic production and resistance
• Generation of genomic DNA, PCR, gel electrophoresis
and purification
• Sequencing and Bioinformatics Analysis
11. collect the colony
II. Purification
III. Cryogenic Freezing
10 mL
pipette
S15UPRC-RISEInitials30M01
S :Spring
15 :2015
UPRC: UPR-Cayey
RISE: RISE Program
Initials: Your Initials (MRR)
30: Incubation Temperature in Celsius
M: Media
(T = Tryptic Soy Agar; N = Nutrient Agar; L = LB Agar; M =
RDM; R = R2A; P = 1SP4)
01: Soil Sample Number
spread the
bacteria
medium
broth
80%
glycerol
micro
tube
cultured
medium plate
pipette
scratch the
plate
collect
the mix
test
tube mix
identify the tubes
http://amoya.webnode.es/foros-de-debate/
http://amoya.webnode.es/foros-de-debate/
http://amoya.webnode.es/foros-de-debate/
http://amoya.webnode.es/foros-de-debate/
12. IV. Gram staining
A drop of water in the
center of the slide.
Collect bacteria and add
them to the slide
For 1 minute and
remove it with
water
safranin
ethanol
crystal violet
bacteria
slides
water
inoculation
loop
13. V. Genomic DNA and Polymerase Chain
Reaction (PCR) centrifuge
dry bath ice bath
liquid broth
with bacteria
PCR tube
collect the
supernatant
http://amoya.webnode.es/foros-de-debate/
http://amoya.webnode.es/foros-de-
debate/
http://amoya.webnode.es/foros-
de-debate/
http://amoya.webnode.es/foros-de-debate/
15. VII. Antibiotic Production and Resistance Tests
M. Luteus
E. Coli
Grow bacteria in separate
plates
Divide the plates in two
portions
Dip the paper disk in the
bacteria culture and place it
in a side of the petri dish
Incubator
24 hourshttp://amoya.webnode.es/foros-de-debate/
http://amoya.webnode.es/foros-de-debate
16. VIII. Purification of PCR Products for Sequence
Determination
QIAquick PCR Purification kit
Calculate the
volume of the
buffer required
add calculated amount to PCR
product
Transfer into a QIAquick
column
Centrifugeadd buffer PE
Place the column in a
clean microtube
Pure water
Analyze the sample
http://amoya.webnode.es/foros-de-debate/
http://amoya.webnode.es/foros-de-
debate/
http://amoya.webnode.es/foros-de-debate/
http://amoya.webnode.es/foros-de-debate/
http://amoya.webnode.es/foros-de-
debate/
http://amoya.webnode.es/foros-de-
debate/
http://amoya.webnode.es/foros-
de-debate/
37. Conclusion
• Nine bacteria were isolated from tropical soils of Puerto
Rico and characterized.
• All bacteria are gram positive and seven of nine are
bacilli.
• Four produced antibiotics, two bacteria coexisted with
Escherichia coli or Micrococcus leteus, two bacteria
showed antibiotic resistance to tetracycline.
• Bacteria with antibiotic resistance and antibiotic
production are found in Puerto Rican (tropical) soil.
38. Future Experiments
• Test bacteria for cellulose and oil
degradation capability
• Test antibiotic production with other bacteria
• Repeat the investigation by isolating new
bacteria in order to have a better
geographical distribution
39. Acknowledgments
• RISE Program (Proposal:5R25GMO59429-16)
University of Puerto Rico at Cayey
• Dr. Michael Rubin
Department of Biology, University of Puerto Rico at Cayey
• Dra. Eneida Diaz
RISE Program, Department of Biology, University of Puerto Rico at Cayey
• Dra. Elena González
RISE Program, Department of English , University of Puerto Rico at Cayey
40. Acknowledgments
• Giovanni Cruz
RISE Program, University of Puerto Rico at Cayey
• Lizbeth Pérez
RISE Student, University of Puerto Rico at Cayey
• José Pabón
Department of Biology, University of Puerto Rico at Cayey
• Cristopher Quintanal
Howard Hughes Program, University of Puerto Rico at Cayey
• Laura Ramos
Department of Biology, University of Puerto Rico at Cayey
41. Isolation and Characterization of
Bacteria from Tropical Soils
Alejandra Ferrer1
Nicole S. Rivera1
Jessica Ortiz1
Carolina Huertas1
Dr. Michael Rubin
Date: May 15, 2015
RISE Program
Biology and Chemistry Department
University of Puerto Rico at Cayey
1 This author contributed equally to this project